ArticleScientific reports2026
R3MV: a novel reliable system architecture for skin cancer classification using progressive heterogeneous multiblock model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical picture categorization has been greatly enhanced by the use of deep learning, especially in the timely identification of skin lesions. Still, predictions from a single model remain unreliable due to their susceptibility to variations in the dataset, complicating their application to diverse clinical scenarios. This study introduces a unique CNN, PHMBCNN, designed to enhance classification accuracy using a progressive learning strategy. We propose the R3MV three-tier decision fusion system, which integrates predictions from (i) individual CNN model predictions, (ii) a feature fusion classification architecture, and (iii) a meta-classifier trained on the outputs of the CNN models. The final forecast is reached using a majority voting procedure, which enhances the reliability of the decision. The study utilizes two datasets for skin cancer: PAD_UFES_20 and HAM10000. Incorporating a GRU into the PHMBCNN model results in the PHMBCNN-GRU. The classification accuracy enhanced from 75.70% for the PAD_UFES_20 dataset to 80.69%, and from 92.07% for the HAM10000 dataset to 96.01%. The R3MV system design achieves 81.78% for PAD_UFES_20 and 99.3% for HAM10000.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.